Literature DB >> 1613119

Genetic aspects of drug disposition and therapeutics.

R J Guttendorf1, P J Wedlund.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1613119     DOI： 10.1002/j.1552-4604.1992.tb03814.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  4 in total

Review 1.  Cytochrome P450 Organization and Function Are Modulated by Endoplasmic Reticulum Phospholipid Heterogeneity.

Authors:  Lauren M Brignac-Huber; Ji Won Park; James R Reed; Wayne L Backes
Journal:  Drug Metab Dispos       Date:  2016-05-27       Impact factor: 3.922

2.  Pharmacokinetics of the antianginal agent perhexiline: relationship between metabolic ratio and steady-state dose.

Authors:  Benedetta C Sallustio; Ian S Westley; Raymond G Morris
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

3.  Role of cytochrome P4502D6 in the metabolism of brofaromine. A new selective MAO-A inhibitor.

Authors:  N Feifel; K Kucher; L Fuchs; M Jedrychowski; E Schmidt; K H Antonin; P R Bieck; C H Gleiter
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 4.  Clinical pharmacokinetics of antidepressants in the elderly. Therapeutic implications.

Authors:  L L von Moltke; D J Greenblatt; R I Shader
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.